-
Careers
Our employees enjoy an energized, collaborative environment that is committed to excellence and focused on results.
We strive to be an employer-of-choice by fostering an environment that is both professionally and personally rewarding. We encourage continuous career development through training and internal advancement within the Company.
Search
| (ENZN) NASDAQ | |||
| Last Trade | 9.81 | ||
| Change(%) |  | 0.00 | |
| Volume | 271686 | ||
| 1:37 PM - Mar 09, 2010 | |||
News
-
09-10-2009
Enzon to Present at NewsMakers...
Enzon to Present at NewsMakers in the Biotech Industry Conference
-
07-27-2009
Enzon to Release Second Quarte...
Enzon to Release Second Quarter 2009 Earnings on Tuesday, August 4, 2009; Conference Call and Webcast to Follow
-
07-27-2009
Enzon to Present at BMO Focus...
Enzon to Present at BMO Focus on Healthcare Conference
-
07-23-2009
Enzon Enhances Governance with...
Enzon Enhances Governance with the Addition of a New Non-Executive Chairman and New Independent Director
-
02-04-2009
Enzon to Present at 11th Annua...
Enzon to Present at 11th Annual BIO CEO & Investor Conference
-
01-28-2009
Enzon Nominates Two New Candid...
Enzon Nominates Two New Candidates for its Board of Directors
-
10-27-2008
Enzon's HIF-1 alpha Antagonist...
Enzon's HIF-1 alpha Antagonist Shows Antitumor Activity
--Innovative and diverse pipeline advances-- -
02-12-2008
Enzon Pharmaceuticals to Add N...
Enzon Pharmaceuticals to Add New Independent Director to Board
-
04-29-2009
Enzon to Release First Quarter...
Enzon to Release First Quarter 2009 Earnings on Thursday, May 7, 2009; Conference Call and Webcast to Follow
-
04-23-2009
Enzon's Board of Directors Rea...
Enzon's Board of Directors Reaffirms Support of its Chairman and CEO
-
05-22-2008
Enzon Stockholders Approve Com...
Enzon Stockholders Approve Company Proposals at 2008 Annual Meeting
-
10-30-2007
Enzon Initiates Second Phase 1...
Enzon Initiates Second Phase 1 Study of Its HIF-1 Alpha Antagonist